Acarizax

Acarizax is a sublingual immunotherapy treatment designed to help manage allergies triggered by dust mites. It contains extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae, common allergens found in households. This product is manufactured by Alk-Abello A/S in the EU.

Acarizax is used for sublingual immunotherapy to reduce allergy symptoms caused by dust mites. It may help alleviate symptoms such as sneezing, nasal congestion, and itchy eyes. This treatment is intended for individuals who are allergic to dust mites and have been diagnosed by a healthcare professional.

Acarizax may cause local reactions at the administration site, such as itching or swelling under the tongue. Some users might experience mild gastrointestinal discomfort. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Acarizax should be used under the guidance of a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Individuals with severe allergic reactions or asthma should exercise caution and consult their doctor before use. Keep the product out of reach of children.

Acarizax may interact with other medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking. Avoid consuming alcohol while using this product, as it may increase the risk of side effects.